SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950103-05-000031
Filing Date
2005-01-07
Accepted
2005-01-07 11:04:32
Documents
1
Group Members
SHIRE PHARMACEUTICALS GROUP PLC

Document Format Files

Seq Description Document Type Size
1 jan0405-biochem_13ga.htm SC 13G/A 43198
  Complete submission text file 0000950103-05-000031.txt   45353
Mailing Address 275 ARMAND FRAPPIER BLVD LAVAL QUEBEC E6 H7V 4A7
Business Address 275 ARMAND-FRAPPIER BLVD LAVAL QUEBEC E6 H7V 4A7 5146811744
SHIRE BIOCHEM INC (Filed by) CIK: 0000867202 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E6 | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 1177 W HASTINGS ST #707 VANCOUVER BC CANADA A1 00000
ID BIOMEDICAL CORP (Subject) CIK: 0000889330 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45185 | Film No.: 05517263
SIC: 2836 Biological Products, (No Diagnostic Substances)